Nephrology Dialysis Transplantation

Article	Citations
Erratum to: FC041 tubular epithelial cell polyploidy is essential to survive AKI but contributes to CKD progression	182
Correction to: CKD therapy to improve outcomes of immune-mediated glomerular diseases	122
Phosphorus balance calculator: an individualized tool for treatment of hyperphosphatemia in hemodialysis patients	98
Immunoengineering for autoimmune-kidney disease	89
Anti-C1Q monitoring predicts relapses of lupus nephritis	79
#1281 Torque teno virus load in kidney transplantation: association with donor and recipient characteristics and clinical follow-up data	76
#1063 Impact of geriatric nutritional risk index on renal function in elderly chronic kidney disease patients treated with SGLT2 inhibitors	74
#2649 Investigation of the Rac1-SGK1 pathway and therapeutic effects of finerenone and Rac1 inhibition in a Fabry disease podocyte model	69
#2706 Genetically determined reduction of renal carbonic anhydrase 12 is associated with decreased kidney function and increased serum urate	63
#2398 Exogenous a-Klotho supplementation significantly prolongs survival in a mouse model of alport syndrome, with comparable outcomes to RASi	62
#291 Prevalence and patterns of intradialytic arterial oxygen saturation instability: observations in a large U.S. hemodialysis cohort	58
#2590 Evolutionary origins of polycystic kidney disease genes: insights from emerging phylogenomic methodologies	57
#3257 Urinary metabolomics in nephrotic syndrome: the experience of “Fondazione Policlinico Universitario A. Gemelli”	56
#2588 Renal trajectories in the french RaDiCo Alport syndrome cohort	55
#1881 Evaluating the clinical and economic impact of SGLT-2 inhibitors for CKD management in the UK: insights from the IMPACT CKD microsimulation model	54
#2889 Changes in proteinuria and kidney function in subgroups of patients with IgAN defined by baseline Gd-IgA1 levels in a Phase 1/2 study of zigakibart	53
#949 Vitamin K dependent proteins and bone quality in the first year after kidney transplantation	50
#1685 Multimodal spatial profiling of microvascular inflammation in kidney allografts	49
#3134 Implementation of an iohexol-based GFR-measurement in clinical routine	49
#960 A single-centre service evaluation of patient-centred twice-weekly dialysis delivery	47
#1922 Association of parathyroid hormone and alkaline phosphatase with fracture risk in patients with chronic kidney disease not on dialysis	45
#2638 Recombinant zoster vaccine (RZV) confers persistent immune responses with no safety concerns 4 to 8 years after vaccination of adults with renal transplant	45
#3063 Real-world utility of the International IgA Nephropathy Prediction Tool in a tertiary referral centre of nephrology	45
#3385 The short and long-term accuracy of urinary C-C motif Chemokine-14 in an ICU population	45
#623 SGLT2 inhibitors in adult patients with Alport syndrome: a single center Italian experience	44

#1796 The impact of metabolic syndrome components on renal function in patients with heart failure	44
#2271 SGLT2 inhibition triggers aestivation-like metabolic switches for water conservation in patients with heart failure—results from DAPA-Shuttle1, a randomized, placebo-controlled trial	43
#1727 Kidney function associated with mortality in hantavirus infection: a cohort study in BRAZIL	42
#2731 Legacy effect of pretransplant immunosuppression in kidney transplant recipients with crescentic glomerulonephritis	41
#2266 Integrating palliative care into nephrology: a single-center “action-research” process	40
#147 Evidence of impaired myocardial perfusion reserve in asymptomatic non-diabetic patients with advanced CKD	36
#3777 Roles of antiHLA antibodies in the onset of MACE in a population of patients on dialysis and on the waiting list for kidney transplant. A retrospective single-center study	36
#3716 Change in mGFR following bariatric surgery: A case-crossover study	35
#3268 Cognitive decline in hemodialysis patients : a prospective cross-sectional study analysing sociodemographic and clinical determinants	35
#2190 The protective effects of a ketogenic diet in experimental glomerulonephritis are independent of the Hca2 receptor	34
#1644 Evaluation of clinical consequences in diverse forms of fistula elevation procedure	34
#3842 Significant association between B lymphocytes and their subpopulations with peripheral T follicular cells is evident in patients with systemic lupus erythematosus (SLE) at remission	34
#450 Comparison of Thymoglobulin® vs Grafalon® as induction treatment in kidney transplantation with maastricht type III donor	33
#2491 Exploring the association between non-alcoholic fatty liver disease and chronic kidney disease: insights from NHANES 1999–2016	33
#3389 Ultrasound evaluation of fluid overload in hemodialysis patients: comparison between VExUS score and lung ultrasound in a cross-sectional study	33
#3313 A novel identification of anti-hypertensive drug spironolactone as an inhibitor of paraoxonase 2 lactonase and anti-ROS activities	33
#3075 Comparison of β-blocker with other anti-hypertensive drugs in patients with chronic kidney disease in Korea: a national health insurance data	33
#2661 Interplay between polymorphism in the EDNRA gene and endothelin-1 concentration in the blood of patients with chronic kidney disease	33
#1100 “Unraveling the genetic complexity of autosomal dominant polycystic kidney disease: insights from gene conversion events”	33
#1519 Granulomatous interstitial nephritis in a patient with metastatic melanoma on target therapy with dabrafenib and trametinib: a case report	32
#2980 Association between body mass index and nephrolithiasis markers in the Mexican population	32
#1793 Renal protective effect of SGLT2 inhibitors in patients with Fabry disease	31
#1085 Acute kidney injury in Iraqi cancer patients treated with immune checkpoint inhibitors. (project ICI-AKI Iraq) interim analysis	31
#3387 Hepatitis, acute kidney injury and myositis due to atorvastatin	31
#1795 Next-generation sequencing in chronic kidney disease of unknown etiology: a step toward precision medicine	31
#3480 Dehydration and hypertension differently prime intrinsic and pre-renal AKI	31
#1715 Online prediction of dialysis adequacy failure in hemodialysis	30
#3838 Hungry bone syndrome (HBS) as an outcome of parathyroidectomy as a treatment of hyperparathyroidism in a third level hospital in a medium-income country	30
#2782 Clinician usage and perception of an AI-based model predicting peritoneal dialysis dropouts	29
Long-term lumasiran therapy final results from a Phase 2 open-label extension study in primary hyperoxaluria	29
#3368 The implementation of a multi-faceted cardio-renal service on heart failure and renal outcomes: a retrospective cohort study	29
#3225 Integrating telemedicine into peritoneal dialysis: a holistic model for palliative care in advanced CKD	29
Intravenous methylprednisolone for nephrotic syndrome with minimal change lesions: a randomized controlled trial	29
#3692 Granulomatous interstitial nephritis and immunodeficiency—a link to remember	29
On the fragility of outcome measures of two individual patient data analyses from randomized controlled trials on online haemodiafiltration	29
#1237 Management of dyslipidaemia with evolocumab in kidney transplant recipients	28
MO1005: Analysis of Expression of Immune System Genes that are Responsible for Activation and Inhibition of T-Cell Immune Response in Renal Transplant Recipients after Extracorporeal Photochemotherapy	28
Cognitive deficits associate with cerebral hypoxia during hemodialysis	28
MO197: Change in the Level Of NFKBP65 Gene Expression in the Myocardium and Kidneys of Wistar Rats and Spontaneously Hypertensive Rats (SHR) That Received Diet Rich in NACL	28
#2396 The potential of human-derived macrophages to study autosomal dominant polycystic kidney disease (ADPKD)	28
#3055 Replacement of tunneled cuffed hemodialysis catheters on coated guidewire: a strategic approach to treat CVC-related infections	28
FC077: Cystatin C Testing Improves Risk Stratification Associated with Chronic Kidney Disease Without Adopting Age-Adapted Diagnostic Thresholds: A UK Biobank Study	27
FC029: A Multivariate Model Identifies Genotype, Hypertension and Kidney Length as Independent Baseline Predictors of Disease Progression in a Longitudinal Autosomal Dominant Polycystic Kidney Disease	27
#2387 Case study of a patient with gouty nephropathy treated with immunosorbent therapy	27
#4264 PERITONEAL DIALYSIS AFTER FAILED KIDNEY TRANSPLANT: A SUITABLE OPTION	27
MO227: Anca-Associated Vasculitis Following Pfizer-Biontech COVID-19 Vaccine: True Association or Circumstantial?	27
#4176 ROLE OF KIDNEY FUNCTION ON NRF2 MRNA LEVELS IN TYPE-2 DIABETES	26
#6120 MIRNA PROFILING OF URINARY EXTRACELLULAR VESICLES (EVS) IN TBMN AND CFHR5 NEPHROPATHY FOR THE IDENTIFICATION OF NOVEL DISEASE BIOMARKERS	26
#675 Application of ANCA-associated vasculitis Histopathological Classification and Renal Risk Score for prediction of end-stage kidney disease	26
#802 CENSUS-EU: a cross-sectional, study to assess the prevalence and burden of chronic kidney disease-associated pruritus in Europe	26

#3968 DIFFERENCES IN MENTAL HEALTH STATUS DURING COVID-19 PANDEMIC BETWEEN IN-CENTER HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS	26
#3140 Investigating the impact of Anti-IL5 therapy in eosinophilic granulomatosis with polyangiitis (EGPA): a three year longitudinal perspective	26
#606 Impact of real-world off-label dose of apixaban on long-term clinical outcomes in patients with atrial fibrillation and chronic kidney disease	26
MO916: Anxiety and Depression Among Dialysis Centre Staff and Haemodialysis Patients During the COVID-19 Pandemic	26
#6279 ESKD TREATMENTS: A DIFFICULT CHOICE TO ELDERLY PATIENTS?	25
#3144 KIDNEY TRANSPLANT-RELATED KNOWLEDGE AMONG SOUTH ASIAN COMPARED TO WHITE CANADIAN PATIENTS	25
#2528 APOL1 GENOTYPING AND PROTEINURIC KIDNEY DISEASE IN EUROPE	25
MO1029: Is there a Relationship Between Fibroblast Growth Factor 23 and Blood Pressure in Children with Chronic Kidney Disease?	25
MO142: Urinary Hemopexin  As a Marker of Lupus Activity Among Egyptian SLE Patients with Proliferative Lupus Nephritis	25
#2294 Muscle ultrasound as a tool for morphofunctional assessment in patients with chronic kidney disease	25
#2917 Desensitization techniques in ABO-incompatible renal transplantation: efficacy and analysis of complications	24
#1818 Association of combined systemic inflammatory indices with the severity and outcome of tunnelled hemodialysis catheter-related bacteremia	24
MO144: Behind the Scenes: A Year in an Onco-Nephrology Outpatient Clinic in Italy	24
#2118 Monitoring hemodynamics in dialysis: on the feasibility of semi-continuous and multifrequency thoracic bioimpedance measurements by a wearable device	24
#1350 Finerenone in real-life clinical practice: first results from a pilot study	24
#3140 THE WEST OF SCOTLAND AND THROMBOTIC MICROANGIOPATHY	24
#4585 POST-TRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER: COMPARISON OF RISK AND PROGNOSTIC FACTORS BETWEEN KIDNEY AND OTHER ORGAN TRANSPLANT RECIPIENTS	24
#5285 SERUM IRON AND NUTRITIONAL STATUS ARE ASSOCIATED IN PATIENTS WITH CHRONIC KIDNEY DISEASE	24
MO048: Genome-wide studies reveal factors associated with circulating uromodulin and its relations with complex diseases	24
MO1019: Sigma-1 Receptor Agonists are Protective in a Rat Model of Kidney Transplantation	23
#6848 DIABETES AND HEMODIALYSIS ARTERIOVENOUS ACCESS CONSTRUCTION – A RETROSPECTIVE STUDY IN A SINGLE CENTER	23
MO405: Leucine-Rich Alpha-2-Glycoprotein as a Potential Marker of Mesangial Cell Proliferation in Immunoglobulin a Nephropathy	23
MO273: Water Restriction and Age Increase the Risk of Triple Whammy-Induced Acute Kidney Injury	23
#6368 PLATELET TO LYMPHOCYTE RATIO AND SICKLE CELL NEPHROPATHY	23
#4127 MODULATION OF BLOOD PRESSURE THROUGH MICROBIOME EXCHANGE BETWEEN MILAN NORMOTENSIVE AND HYPERTENSIVE STRAINS OF RATS	23
#5536 CIRCULATING LEVELS OF COPEPTIN, GROWTH DIFFERENTIATION FACTOR 15 (GDF15) AND INTERLEUKIN 6 (ILA-6) IN PATIENTS WITH ADVANCED KIDNEY DISEASE	23
#1834 Prevalence of nephrolithiasis in patients with idiopathic hypercalciuria after two decades of follow-up	23
#2695 A Polycystin-1-Bicaudal C1 complex regulates focal adhesion function through integrin beta-1, F-actin organisation and local translation in HKE cells	23
#5730 PERLECAN AS A POTENTIAL BIOMARKER OF CARDIOVASCULAR RISK: ROLE OF ENDOTHELIAL GLYCOCALYX IN CHRONIC KIDNEY DISEASE	23
#5349 CYCLIN D1 AMELIORATES ACUTE KIDNEY INJURY BY IMPROVING FATTY ACID OXIDATION VIA AMPK PATHWAY	22
MO675: A New in Vivo Multi-Photon Microscopy Based Approach to Study the Peritoneal Membrane Changes Induced by Peritoneal Dialysis	22
#3296 ADVERSE MUSCLE COMPOSITION ASSESSED BY MRI ASSOCIATES TO POOR FUNCTIONAL PERFORMANCE AND METABOLIC COMORBIDITIES IN CKD	22
#4720 SEPSIS, AKI AND MORTALITY. SEARCHING FOR NEW MARKERS: OUR EXPERIENCE WITH ENDOGENOUS OUABAIN	22
#761 Effect of ketoanalogue-supplemented very low protein diet in the need to initiate renal replacement in chronic kidney disease patients	22
MO753: Marinobufagenin Predicts Intradialytic Hypotension Episodes in Prevalent Haemodialysis Patients	22
MO522: The Effect of Statin on Anemia in Patients With End-Stage Kidney Disease Receiving Hemodialysis: A Systematic Review and Meta-Analysis	22
#3166 RECOGNITION OF RENAL TUBULAR DYSGENESIS IN ADOLESCENT CKD BY BIALLELIC AGT VARIANTS REQUIRED BROAD GENETIC ANALYSIS	21
#5448 INCIDENCE OF ACUTE PULMONARY EDEMA AFTER THE SYSTEMATIC USE OF ULTRASOUND B-LINES	21
#1315 Management and long-term outcome of recurrent idiopathic FSGS in pediatric renal transplant recipients	21
#651 Diagnostiс criteria of the functional state of the kidneys in patients with type 2 diabetes mellitus	21
MO826: Long-Term Impact of COVID-19 Pandemic on HD Adequacy and Patient Care in Alexandria, Egypt: A Multi-Centre Study	21
#1962 Development of triple-whammy induced pre-renal AKI is highly dependent on the hydration status	21
#2531 AGATSTON INDEX AS A PREDICTOR OF PREDICTION OF THE DEGREE OF HEART VASCULAR DAMAGE IN STAGE 5 CKD PATIENTS RECEIVING PROGRAM HEMODIALYSIS	21
MO766: Sodium Citrate Versus Heparin Locking Solutions for Tunnelled Haemodialysis Catheters: A Retrospective Analysis	21
#3303 SUBOPTIMAL EXTENT OF RAASI RE-INITIATION AFTER DISCONTINUATION FOLLOWING HYPERKALEMIA: AN OBSERVATIONAL STUDY OF CARDIORENAL PATIENTS IN THE US AND JAPAN	21
#2728 THROMBOINFLAMMATORY BIOMARKERS AND THEIR RELATIONSHIP WITH CIRCULATING GLYCOSAMINOGLYCANS IN END-STAGE RENAL DISEASE PATIENTS	21
#5510 CKD-ASSOCIATED PRURITUS SEVERITY AND ITS ASSOCIATION WITH BODY DISTRIBUTION AND EQ-5D HEALTH-RELATED QUALITY OF LIFE IN HAEMODIALYSIS PATIENTS	20
#4063 APELIN INCREASES FOREARM BLOOD FLOW IN CHRONIC KIDNEY DISEASE	20
#1795 Diverse histological findings of kidney injury in cancer patients on immunotherapy- impact on clinical management	20
#3121 THE EFFECTIVENESS OF A GLUTEN-FREE DIET IN PATIENTS WITH IGA NEPHROPATHY	20
#2671 Renal tubular epithelial FFAR4 improves cellular senescence to alleviate interstitial fibrosis in CKD	20
#1716 IgA nephropathy: our center's experience	20
#6005 COMPARISON OF SEMAGLUTIDE ORAL VS SUBCUTANEOUS IN CHRONIC KIDNEY DISEASE (CKD)	20
#1076 DNA hypomethylation of Syk induces oxidative stress and apoptosis via the PKCβ/ P66shc signaling pathway in diabetic kidney disease	20
#635 Effect of multi-biomarker panels based on urinary N-terminal osteopontin on prediction of diabetic kidney disease in patients with diabetes mellitus	20
#5532 COVID-19 INFECTION MODIFIES GLOMERULAR DISEASE EVOLUTION	20
#2251 Long-term systolic blood pressure variability as an independent risk factor for cardiovascular events in kidney transplant recipients	20
#1846 Oxalate nephropathy in diabetic kidney disease: another factor to take into account?	20
MO869: SARS-COV-2 Neutralizing Antibodies in Patients on Hemodialysis After Vaccination	19
#6891 MACHINE LEARNING NEPHROPATHOLOGY DIAGNOSTICS OF THROMBOTIC MICROANGIOPATHIES	19
#821 Kibra mediates the activation of hippo by classic signal pathway related to NPHP1 defect	19
#5958 VALUE OF EXOME SEQUENCING “FIRST” FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE	19
#1737 Kidney function, kidney function decline, and the risk of abdominal aortic aneurysm: the Stockholm CREAtinine Measurements (SCREAM) project	19
#972 A Novel Single Compound from Chinese Herbs as a Potential Candidate for Reducing obesity induced diabetic nephropathy via ATF3-RARRES1 axis pathway	19
#2556 Therapeutic monitoring in patients with APRT deficiency using UPLC-MS/MS-based plasma assay	19
FC033: Genome-Wide Association Meta-Analysis Identifies Novel Loci for Kidney Failure	19
MO841: Anxiety and Depression in Maintenance Hemodialysis Patients: Prevalence and Their Effects on Health-Related Quality of Life	19
#5785 ACUTE KIDNEY INJURY AS A RISK FACTOR FOR THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE AND MORTALITY IN HOSPITALIZED PATIENTS	19
#2529 The role of the circadian clock system in the transition from acute kidney injury to chronic kidney disease	19
#3812 ARE KIDNEY CYSTS MORE COMMON IN PEOPLE WITH COL4A3/COL4A4 PATHOGENIC VARIANTS?	19
#3641 DOES IBANDRONATE OR CALCIUM AND VITAMIN D MAINTAIN OR IMPROVE BONE MICROARCHITECTURE IN THE FIRST YEAR AFTER KIDNEY TRANSPLANTATION?	19
#2740 Pregnancy outcomes in patients with IgA nephropathy and the impact of pregnancy on the renal disease	18
#2963 Light chain deposition in the kidney is more frequent in patients with proliferative lupus nephritis	18
#860 The role of immunocorrection in the treatment of patients chronic pyelonephritis	18
#6915 IMMUNOLOGIC EFFECTS OF THE DECREASE OF IMMUNOSUPPRESSION AFTER SARS-COV-2 INFECTION IN KIDNEY TRASPLANT RECIPIENTS	18
#4758 IMPACT OF GENDER ON CHRONIC KIDNEY DISEASE IN ELDERLY	18
#2699 Rare glomerular microangiopathy: clinicopathological characteristics and prognosis	18
#1839 Evaluating the severity of restless legs syndrome in chronic kidney disease patients across different renal replacement therapies	18
#814 Inflammatory biomarkers and progression of diabetic kidney disease	18
#4554 FRAX® ASSOCIATION, BONE DENSITOMETRY, BIOCHEMICAL PARAMETERS OF BONE MINERAL METABOLISM AND ADVANCED CHRONIC KIDNEY DISEASE	18

#3958 PROTON PUMP INHIBITORS AND THE RISK OF ACUTE KIDNEY INJURY IN PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS: A POPULATION-BASED COHORT STUDY	18
#543 Cognitive improvement in end stage renal disease patients post transplantation—a prospective observational study	18
#2868 PREDICTION OF MAJOR GASTROINTESTINAL BLEEDING EVENTS IN HEMODIALYSIS	17
MO708: Association of Atherogenic Index of Plasma (AIP) with Mortality in Chinese and Swedish End-Stage Kidney Disease Patients: Results from Two Cohorts	17
FC089: The Absence of Sting Prevents Peritoneal Damage in a Murine Model of Peritoneal Fibrosis	17
#6442 HOW CAN IT BE NEPHROANGIOSCLEROSIS? HE´S BEING TREATED ONLY WITH ONE ANTIHYPERTENSIVE DRUG	17
#2394 Inhibition of ACSS2-mediated H3K9 crotonylation alleviates kidney fibrosis via IL-1β-dependent macrophage activation and tubular cell senescence	17
#2116 Socioeconomic position and incidence of chronic kidney disease in Central Italy	17
MO688: Peritoneal Protein Clearance, Inflammation, Nutrition and Overhydration in PD Patients: Looking for the Culprit	17
#2439 The association between vitamin D deficiency and sarcopenia in patients with pre-dialysis CKD	17
#3261 SAR131675, A SELECTIVE VEGFR3 INHIBITOR, AMELIORATES RENAL INFLAMMATION AND LYMPHANGIOGENESIS IN THE MURINE LUPUS NEPHRITIS MODEL	17
#2685 SLC34A2 EXACERBATES TUBULAR INTERSTITIAL FIBROSIS VIA INDUCTION OF APOPTOSIS AND CELL CYCLE ARREST IN S PHASE	17
#1704 GLP-1RA versus DPP-4 inhibitors and rates of hyperkalemia and discontinuation of renin-angiotensin system (RAS) blockade in Swedish routine care	17
#5142 THE NATURAL HISTORY OF FSGS IN THE GERMAN CHRONIC KIDNEY DISEASE (GCKD) COHORT	17
#6456 DSA-NEGATIVE MICROVASCULAR INFLAMMATION IN KIDNEY TRANSPLANT BIOPSIES: GENE EXPRESSION COMPARISON WITH NATIVE AND TRANSPLANT KIDNEY CONTROLS	17
MO998: Kidney Donor Risk Index Correlates with the Worse Recipients And Grafts Survival in a Polish Cohort	17
#1304 Clinical characteristics of acute kidney injury caused by Phytolaccaceae ingestion	17
#5599 FEBUXOSTAT IN COMBINATION WITH ANAKINRA OR PH NEUTRALIZATION IMPROVE THE OUTCOMES IN HYPERURICEMIA-RELATED URIC ACID CRYSTALLURIA IN MICE	17
MO081: Ambulatory Blood Pressure Trajectories and Blood Pressure Variability in Kidney Transplant Recipients: A Comparative Study Against Chronic Kidney Disease Patients	16
#2388 Relevance of anti-PLA2R levels in therapy decision and prediction of therapy outcome in patients with membranous nephropathy	16
#2450 Alternative splicing in podocytes under mechanical stress: a new perspective for the pathogenic effect of glomerular hypertension	16
#289 Lipocalin-2 promotes cardiovascular calcification in chronic kidney disease by upregulating STAT3/NCOA4-mediated ferritinophagy and ferroptosis	16
#5882 BENEFIT OF LONG-TERM TOLVAPTAN ADMINISTRATION ON KIDNEY DISEASE PROGRESSION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: A SINGLE-CENTRE EXPERIENCE	16
MO275: A Biomarker of Acute Kidney Injury from Proven Renal Origin	16
#672 Intradialytic hypotension and adverse symptoms are not related	16
MO550: Vascular Cells Senescence and Modifications in NRF2 Pathway in a Model of URaEMIC Vascular Calcification	16
#1297 Approaches to renal response assessment in rare monoclonal immunoglobulin related glomerulopathies	16
#1906 Lung ultrasound as a valid tool for fluid assessment in dialysis patients: a systematic review	16
#5645 SHORT-CHAIN FATTY ACIDS, PROPIONATE AND BUTYRATE, RESEMBLE THE BENEFICIAL EFFECTS OF VITAMIN D DURING ACUTE KIDNEY DAMAGE	16
#598 Successful application of allo-hemodialysis in a porcine model of embolization-induced acute kidney injury	15
#3848 ORIGIN TRIAL: 24-WK PRIMARY ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PH2B STUDY OF ATACICEPT IN PATIENTS WITH IGAN	15
Are patients with primary glomerular disease at increased risk of malignancy?	15
Quantifying the benefits of remission duration in focal and segmental glomerulosclerosis	15
Neutralizing the IL-7Rα limits injury in experimental ANCA-associated glomerulonephritis	15
MO490: Fast and High Phosphate Reduction With Lanthanum Dioxycarbonate Versus Selevamer In In-Vivo Study	15
#1683 Gut permeability, circulating bacterial fragments, and left ventricular strain in peritoneal dialysis	15
#1914 Comprehensive single-cell sequencing and lipidomics identify diverse injury states and cholesterol dynamics of the PTs in AKI-to-CKD transition	15
#2967 C-reactive protein/serum chloride ratio: a novel marker of all-cause mortality in prevalent chronic haemodialysis patients	15
#1157 Body mass and fluid balance in dialysis: global profiles in Apollo Dial DB	15
Measuring quality of life in trials including patients on haemodialysis: methodological issues surrounding the use of the Kidney Disease Quality of Life Questionnaire	15
FHL2 in arterial medial calcification in chronic kidney disease	15
CKD as a risk factor for severe COVID-19: a critical look back and lessons for the future	15
#2745 New strategies for capturing undiagnosed chronic kidney disease in patients at risk	15
#6896 A SCREENING AND CLINICAL MANIFESTATIONS OF FABRY DISEASE IN PATIENTS ATTENDING DIALYSIS AND NEPHROLOGY CLINICS IN DURBAN, SOUTH AFRICA	15
MO556: Markers of Oxidative Stress and Coronary Calcifications in Chronic Hemodialysis Patients	15
#1916 Infective endocarditis in young female hemodialysis patient: a case report and literature review	15
Hippocampal subfield morphology in regular hemodialysis patients	15
Transition of care of adolescent kidney transplant recipients—a call to action	15
Peer-reviewing and medical publication	15
#1936 Investigating genetic and environmental modifiers of autosomal dominant polycystic kidney disease through a distinct PKD2-founder variant (p.Arg803*)	15
#801 Impact of delayed graft function on cardiovascular events in kidney transplant recipients	15
#6672 THE DEVELOPMENT OF A COMMUNITY-NEPHROLOGY, MULTI-DISCIPLINARY SERVICE	15
#6668 PREDICTION OF REMAINING RENAL FUNCTION IN PATIENTS UNDERGOING RADICAL NEPHRECTOMY DUE TO RENAL TUMOUR MASS AND AFTER NEPHRECTOMY IN LIVING DONORS	15
Plasma endotrophin, reflecting tissue fibrosis, is associated with graft failure and mortality in KTRs: results from two prospective cohort studies	14
Time trends in preemptive kidney transplantation in Europe: an ERA registry study	14
#2550 Micro(nano)plastics in human urine: a surprising contrast between Chongqing's urban and rural regions	14
Towards carbon footprint measurement of the ERA Congress: five key strategies for greener events	14
MO380: Bio-Conductivity Measurement for Electrical Impedance Tomography (EIT) in Chronic Kidney Disease—A Non-Invasive and Portable Monitoring Approach	14
Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies: biological challenges and clinical implications	14
Uromodulin biology	14
#2984 SLE associated fibrillary glomerulonephritis vs SLE nephritis with fibrils: can a straightforward distinction always be made?	14
FC006: Sex Differences in the Recognition, Monitoring and Management of Chronic Kidney Disease in Health Care	14
Non-crystalline light chain proximal tubulopathy, a morphologically protean entity	14
#1048 Why are felids at such a high risk of chronic kidney disease?	14
Age and gender differences in symptom experience and health-related quality of life in kidney transplant recipients: a cross-sectional study	14
Key enzyme in charge of ketone reabsorption of renal tubular SMCT1 may be a new target in diabetic kidney disease	14
FC051: Atacicept Reduces Serum ANTI-GD-IGA1 Levels in IgAN Patients	13
#4735 USEFULNESS OF CYSTATIN C IN MEASURING RENAL FUNCTION AND PREDICTING METHOTREXATE ASSOCIATED TOXICITIES IN PATIENTS WITH RHEUMATOID ARTHRITIS	13
MO589: Exertion2 Trial: THE Weight Gain Prevention in Renal Transplant Online Study—a Randomized Controlled Feasibility Trial	13
Rationale, design and baseline characteristics of REMODEL, a mechanism-of-action trial with semaglutide in people with type 2 diabetes and chronic kidney disease	13
Management of heart failure in patients with kidney disease—updates from the 2021 ESC guidelines	13
Long-term outcomes of COVID-19 survivors with hospital AKI: association with time to recovery from AKI	13
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy	13
#4878 STUDYING THE EFFECTIVENESS OF PRASUGREL AND CLOPIDOGEL IN PATIENTS WITH CHRONIC LOWER LIMB ISCHEMIA WITH STAGE 2 CKD	13
Teneligliptin and empagliflozin attenuate ferroptosis-mediated acute tubular injury	13
Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in paediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT Alport	13
Long-term outcome of kidney function in patients with ANCA-associated vasculitis	13
#560 The representation of multimorbidity and frailty in the development and validation of kidney failure risk prediction models – a systematic review	13
#2067 Prediction of gastrointestinal bleeding hospitalization risk in hemodialysis using machine learning techniques	13
Metabolic dysfunction–associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease	13
Pediatric kidney care experience after the 2023 Türkiye earthquake	13
#5093 DIALYSIS PATIENTS AND BNT162B2MRNA VACCINE TYPE ARE RISK FACTORS FOR IMMUNITY FADING 9 MONTHS AFTER SARS-COV-2MRNA VACCINATION (DIA-VACC STUDY)	12
FC007: The Impact of Sex on the Risk Of Major Adverse Cardiovascular Events in Older Adults with Advanced Chronic Kidney Disease: Results from the Equal Study	12
#3520 THE RELATIONSHIPS OF BONE TURNOVER MARKERS AND CEREBRAL WHITE MATTER ALTERATIONS IN PATIENTS UNDERGOING HEMODIALYSIS	12
#5734 RENAL AUTOLOGOUS CELL THERAPY (REACT™) FOR DIABETIC CHRONIC KIDNEY DISEASE: PHASE II TRIAL WITH BILATERAL CORTEX INJECTIONS AND RE-DOSING TRIGGERS	12
#4494 DRUG UTILIZATION FOLLOWING INCIDENT CHRONIC KIDNEY DISEASE: AN OBSERVATIONAL STUDY IN THE UNITED STATES AND JAPAN	12
#3459 GLUCOSE-LOWERING THERAPIES IN END STAGE RENAL DISEASE: HOW CAN WE PREDICT THE RISK OF HYPOGLYCAEMIA?	12
#5341 EFFECTS OF URIC ACID-LOWERING THERAPY ON RENAL OUTCOMES IN CKD PATIENTS WITH ASYMPTOMATIC HYPERURICEMIA: A SYSTEMATIC REVIEW AND META-ANALYSIS	12
MO191: Humoral Immune Response of the Additional Chadox1 NCOV-19 Vaccine Following a Two-Dose Inactivated Whole-Virus SARS-COV-2 Vaccination in Patients on Dialysis	12
#6898 CATHETER RELATED BLOODSTREAM INFECTION IN NON-TUNNELED HEMODIALYSIS CATHETERS IN A RESOURCE-LIMITED HOSPITAL IN MERIDA, YUCATAN, MEXICO	12
#4344 CHANGES IN ENERGY METABOLISM IN THE KIDNEY WITH TUBULOINTERSTITIAL FIBROSIS: AN EX VIVO WHOLE TISSUE 2D-COSY APPROACH	12
MO019: Preclinical Efficacy of Direct AMPK Activation with a Novel Small Molecule–PXL770–For the Treatment of Autosomal Dominant Polycystic Kidney Disease	12
MO402: Symmetric Dimethylarginine Inhibits Renal Fibrosis in Obstructive Kidneys	12
#6691 COMPREHENSIVE TWO-DAY IN-HOSPITAL ASSESSMENT MODE IS ASSOCIATED WITH THREE-YEAR AND FIVE-YEAR MORTALITY IN PERITONEAL DIALYSIS PATIENTS	12
#228 APOL1 variants and chronic kidney disease in Morocco: case control study	12